COMMUNIQUÉS West-GlobeNewswire

MPX Adds a Fourth Dispensary in Phoenix and Triples Capacity for MPX Concentrate Production in Arizona
09/04/2018
TORONTO, April 09, 2018 (GLOBE NEWSWIRE) -- MPX Bioceutical Corporation (“ MPX ” or the “ Company ”) (CSE:MPX) (OTC:MPXEF) is pleased to announce that the official opening of the its newest “Health for Life” medical [...]
Clinical Laserthermia Systems Introduces MRI-Guided Laser Ablation System for Minimally-Invasive Treatment of Soft Tissue
09/04/2018
FRAMINGHAM, Mass., April 09, 2018 (GLOBE NEWSWIRE) -- Clinical Laserthermia Systems Americas, Inc . (CLS) a subsidiary of CLS AB in Lund, Sweden, today announced the availability of its TRANBERG® Thermal Therapy System [...]
G1 Therapeutics to Present Preclinical Data on CDK4/6 Inhibitors Trilaciclib and G1T38 at the 2018 American Association for Cancer Research (AACR) Annual Meeting
09/04/2018
RESEARCH TRIANGLE PARK, N.C., April 09, 2018 (GLOBE NEWSWIRE) -- G1 Therapeutics, Inc. (Nasdaq: GTHX ), a clinical-stage oncology company, today announced that preclinical data on both of the company’s CDK4/6 inhibitors [...]
RedHill Biopharma Provides Semi-Annual Business Update
09/04/2018
TEL-AVIV, Israel and RALEIGH, N.C., April 09, 2018 (GLOBE NEWSWIRE) -- RedHill Biopharma Ltd. (NASDAQ: RDHL ) (Tel-Aviv Stock Exchange:RDHL) (“RedHill” or the “Company”), a specialty biopharmaceutical company primarily [...]
Tyme Provides Clinical and Corporate Update for Fiscal Year End 2018
09/04/2018
NEW YORK, April 09, 2018 (GLOBE NEWSWIRE) -- Tyme Technologies, Inc. (NASDAQ: TYME ), a clinical-stage oncology company developing metabolically-based cancer therapeutics, today announced a clinical and corporate update [...]
BioVie Inc. (OTCQB:BIVI) Attains Milestone
09/04/2018
Company Reaches 50% Patient Enrollment in Phase 2a Clinical Trial of BIV201 for Refractory Ascites BEVERLY, Mass., April 09, 2018 (GLOBE NEWSWIRE) -- BioVie Inc. (OTCQB:BIVI), a clinical-stage company focused on the [...]
Auris Medical Announces Early Repayment of Part of its Loan Facility
09/04/2018
Zug, Switzerland, April 9, 2018 - Auris Medical Holding AG (NASDAQ: EARS), a clinical-stage company dedicated to developing therapeutics that address important unmet medical needs in neurotology, today announced the [...]
PotNetwork Holding, Inc.'s Diamond CBD, Inc. to be featured at 2018 Telecom Review Summit held in Beirut, Lebanon.
09/04/2018
Exponential, Inc. founder and CEO Dom Einhorn to present keynote panel, “The New Start-Up Ecosystem”. FT LAUDERDALE, Fla., April 09, 2018 (GLOBE NEWSWIRE) -- via OTC PR WIRE--PotNetwork Holding, Inc. (OTC Pink:POTN) On [...]
ContraVir Pharmaceuticals Appoints Two New Hepatitis B Experts to Scientific Advisory Board
09/04/2018
EDISON, N.J., April 09, 2018 (GLOBE NEWSWIRE) -- ContraVir Pharmaceuticals, Inc. (NASDAQ: CTRV ), a biopharmaceutical company focused on the development and commercialization of targeted antiviral therapies, announced [...]
RavenQuest Common Shares Listed on OTC now DTC Eligible
09/04/2018
VANCOUVER, British Columbia, April 09, 2018 (GLOBE NEWSWIRE) -- RavenQuest BioMed Inc. (the “Company” or “RavenQuest”) – (CSE:RQB) (OTCQB:RVVQF) (Frankfurt: 1IT ) today announced that it has secured DTC Eligibility for [...]
Enzymatica AB: New ColdZyme study in elite athletes confirms preventive effect and reduced duration of illness
09/04/2018
News Lund April 9, 2018 New ColdZyme study in elite athletes confirms preventive effect and reduced duration of illness Enzymatica is now publishing the results of a second study 1 in which elite athletes used ColdZyme [...]
Transactions under Novozymes’ stock buyback program
09/04/2018
Please read the full announcement in the attached PDF Attachment 2018_12_Stock_Buybackprogram_EN
MPI - Oncology Venture exercises option to inlicense Dovitinib a Phase 3 Multi Tyrosine Kinase Inhibitor
09/04/2018
Hoersholm, Denmark, April 9, 2018 - Medical Prognosis Institute A/S (MPI:ST) ("MPI" or the "Company") today announced that Oncology Venture has entered into an agreement with Novartis Pharma AG (Basel, Switzerland) for [...]
Solon Eiendom ASA : Strategic equity investment by Union - and subsequent offering
09/04/2018
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, AUSTRALIA, CANADA OR JAPAN, OR ANY OTHER JURISDICTION IN WHICH THE RELEASE, PUBLICATION OR [...]
Solon Eiendom ASA : KEY INFORMATION RELATING TO THE SUBSEQUENT OFFERING
09/04/2018
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, AUSTRALIA, CANADA OR JAPAN, OR ANY OTHER JURISDICTION IN WHICH THE RELEASE, PUBLICATION OR [...]
RECORDATI ACQUIRES INTERNATIONAL RIGHTS TO CYSTAGON® FROM MYLAN
09/04/2018
Milan, 9 April 2018 - Recordati announces the completion of an agreement with Mylan for the acquisition of the rights to Cystagon® (cysteamine bitartrate), indicated for the treatment of proven nephropathic cystinosis [...]
Shire plc : Rule 2.9 Announcement
09/04/2018
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF THAT JURISDICTION. 9 April 2018 Shire [...]
Basilea reports launch of antibiotic Zevtera (ceftobiprole) in Canada by Avir Pharma
09/04/2018
Basel, Switzerland, April 09, 2018 - Basilea Pharmaceutica Ltd. (SIX: BSLN) announced today that its partner Avir Pharma Inc. ("Avir Pharma") has launched Basilea's hospital antibiotic Zevtera ® (ceftobiprole) in Canada [...]
INNATE PHARMA : Upcoming investor conferences
09/04/2018
upcoming investor conferences Marseille, France, April 9, 2018, 7:00 AM CEST Innate Pharma SA (the "Company" - Euronext Paris: FR0010331421 - IPH) today announces that it will be present at the following investor events [...]

Pages